-
Je něco špatně v tomto záznamu ?
Prognostic assessment of T-cells in primary colorectal cancer and paired synchronous or metachronous liver metastasis
A. Trailin, E. Ali, W. Ye, S. Pavlov, L. Červenková, O. Vyčítal, F. Ambrozkiewicz, P. Hošek, O. Daum, V. Liška, K. Hemminki
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
NU21-03-00506
Agentura Pro Zdravotnický Výzkum České Republiky
PubMed
39508720
DOI
10.1002/ijc.35252
Knihovny.cz E-zdroje
- MeSH
- CD8-pozitivní T-lymfocyty imunologie MeSH
- dospělí MeSH
- kolorektální nádory * patologie imunologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mnohočetné primární nádory patologie imunologie MeSH
- nádory jater * sekundární imunologie patologie MeSH
- přežití bez známek nemoci MeSH
- prognóza MeSH
- retrospektivní studie MeSH
- sekundární malignity patologie MeSH
- senioři MeSH
- T-lymfocyty imunologie patologie MeSH
- tumor infiltrující lymfocyty imunologie patologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Prognostic value of T-cells between primary colorectal cancer (pCRC) and its paired synchronous and metachronous liver metastasis (LM) is underinvestigated and is the subject of the present study. We enrolled into this retrospective cohort study patients, who underwent resection of both pCRC and synchronous LM (N = 55) or metachronous LM (N = 44). After immunohistochemical staining for CD3+, CD8+, and CD45R0+ whole slides were scanned and T-cell densities were quantified using QuPath software in tumor center (TC), inner margin (IM), outer margin (OM), and peritumor zone (PT) of pCRC and LM. High densities of CD8+ T-cells in TC, OM and PT of synchronous LM were associated with longer disease-free survival (DFS). Greater densities of CD3+ T-cells in IM and PT and CD8+ T-cells in IM, OM and PT in synchronous LM over pCRC were associated with longer DFS. Greater densities of CD8+ T-cells in the TC and IM and CD3+ T-cells in the IM of pCRC were found in the metachronous over synchronous group. The first novel finding demonstrated that high density of CD8+ T cells in synchronous LM were associated with favorable outcome. The second finding of high CD8+ cell density in pCRC in metachronous over synchronous CRC may provide a mechanistic basis for the delay of metastatic spread. Both findings could be applied clinically with own reference values.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009492
- 003
- CZ-PrNML
- 005
- 20250429134636.0
- 007
- ta
- 008
- 250415s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/ijc.35252 $2 doi
- 035 __
- $a (PubMed)39508720
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Trailin, Andriy $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $1 https://orcid.org/0000000188880759
- 245 10
- $a Prognostic assessment of T-cells in primary colorectal cancer and paired synchronous or metachronous liver metastasis / $c A. Trailin, E. Ali, W. Ye, S. Pavlov, L. Červenková, O. Vyčítal, F. Ambrozkiewicz, P. Hošek, O. Daum, V. Liška, K. Hemminki
- 520 9_
- $a Prognostic value of T-cells between primary colorectal cancer (pCRC) and its paired synchronous and metachronous liver metastasis (LM) is underinvestigated and is the subject of the present study. We enrolled into this retrospective cohort study patients, who underwent resection of both pCRC and synchronous LM (N = 55) or metachronous LM (N = 44). After immunohistochemical staining for CD3+, CD8+, and CD45R0+ whole slides were scanned and T-cell densities were quantified using QuPath software in tumor center (TC), inner margin (IM), outer margin (OM), and peritumor zone (PT) of pCRC and LM. High densities of CD8+ T-cells in TC, OM and PT of synchronous LM were associated with longer disease-free survival (DFS). Greater densities of CD3+ T-cells in IM and PT and CD8+ T-cells in IM, OM and PT in synchronous LM over pCRC were associated with longer DFS. Greater densities of CD8+ T-cells in the TC and IM and CD3+ T-cells in the IM of pCRC were found in the metachronous over synchronous group. The first novel finding demonstrated that high density of CD8+ T cells in synchronous LM were associated with favorable outcome. The second finding of high CD8+ cell density in pCRC in metachronous over synchronous CRC may provide a mechanistic basis for the delay of metastatic spread. Both findings could be applied clinically with own reference values.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nádory jater $x sekundární $x imunologie $x patologie $7 D008113
- 650 12
- $a kolorektální nádory $x patologie $x imunologie $7 D015179
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a CD8-pozitivní T-lymfocyty $x imunologie $7 D018414
- 650 _2
- $a přežití bez známek nemoci $7 D018572
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a mnohočetné primární nádory $x patologie $x imunologie $7 D009378
- 650 _2
- $a T-lymfocyty $x imunologie $x patologie $7 D013601
- 650 _2
- $a sekundární malignity $x patologie $7 D016609
- 650 _2
- $a tumor infiltrující lymfocyty $x imunologie $x patologie $7 D016246
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ali, Esraa $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Ye, Wenjing $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Pavlov, Sergii $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Červenková, Lenka $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Vyčítal, Ondřej $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Ambrozkiewicz, Filip $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Hošek, Petr $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Daum, Ondřej $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Liška, Václav $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Hemminki, Kari $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 773 0_
- $w MED00002298 $t International journal of cancer $x 1097-0215 $g Roč. 156, č. 6 (2025), s. 1282-1292
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39508720 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134631 $b ABA008
- 999 __
- $a ok $b bmc $g 2311088 $s 1246573
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 156 $c 6 $d 1282-1292 $e 20241107 $i 1097-0215 $m International journal of cancer $n Int J Cancer $x MED00002298
- GRA __
- $a NU21-03-00506 $p Agentura Pro Zdravotnický Výzkum České Republiky
- LZP __
- $a Pubmed-20250415